M Johnson

Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA

Nathan Clumeck, F. D. Goebel, Willy Rozenbaum et al. · AIDS · 2001 · 145 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy

Jane R Deayton, Amanda Mocroft, Pauline Wilson et al. · AIDS · 1999 · 106 citations

Medicine, Infectious Diseases, Ophthalmology +15

The Steady‐State Pharmacokinetics of Efavirenz and Nevirapine When Used in Combination in Human Immunodeficiency Virus Type 1–Infected Persons

Agnes I. Veldkamp, Marianne Harris, Julio Montaner et al. · The Journal of Infectious Diseases · 2001 · 57 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape

Richard J. Bingham, Nadia Ahmed, Prem Rangi et al. · International Journal of STD & AIDS · 2011 · 55 citations

Life Sciences, Infectious Diseases, Neurology +17

Interactions between ?-herpesviruses and human immunodeficiency virus in vivo: Evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6

Vincent C. Emery, Mark Atkins, E Frances Bowen et al. · Journal of Medical Virology · 1999 · 50 citations

Life Sciences, Infectious Diseases, Microbiology +12